OCTANe, the Aliso Viejo, Calif.-based industry council set up to nurture and grow the technology ecosystem in Orange County, is on the move.
Last month, the technology council said that it would merge with the Mission Viejo, Calif.-based Orange County Technology Alliance, keeping the OCTANe name. That move, according to OCTANe CEO Bill Carpou, will enable the dual industry alliances to grow their combined events business and further solidify Orange County as a technology super-hub.
Although OCTANe serves a broad mission covering the entire technology community, medical devices continue to be at the heart of its mission. OCTANe was founded with the guidance of Edwards Lifesciences (NYSE:EW) CEO Michael Mussallem and James Mazzo, the head of ophthamology at Carl Zeiss Meditec (ETR:AFX). Both men continue to be active in the council.
That medical device focus has helped OCTANe run 1 of the west coast’s most impactful events, the Medical Device Investor Forum, which this happens Oct. 27-28 in Irvine. Now in its 11th year, the conference is expected to draw roughly 800 medical device executives.
MassDevice.com Publisher and DeviceTalks founder Brian Johnson spent a few minutes chatting with Carpou about the group’s investor forum event, OCTANe’s evolution over the years and what it takes to succeed in business in Orange County.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.